辩证行为疗法痛苦耐受技术治疗强迫症:随机对照试验方案
本研究为前瞻性、单中心、开放标签随机对照试验,计划纳入80名18-40岁强迫症成人患者(ICD-10标准,Y-BOCS≥16),1:1随机分配至12周结构化痛苦耐受技术(DTT)干预组或暴露与反应预防(ERP)活性对照组,主要结局为Y-BOCS测量的强迫症严重程度。
要点
- DTT作为DBT成分,在强迫症中应用尚缺乏充分探索。
- 试验比较12周DTT与标准ERP对强迫症严重程度的影响。
- 纳入标准为ICD-10诊断且Y-BOCS评分≥16的成人患者。
核心结论
- 该试验旨在评估痛苦耐受技术降低强迫症严重程度和改善心理结局的疗效。
研究设计与样本
- 前瞻性、单中心、开放标签随机对照试验,计划招募80名18-40岁强迫症成人患者。
- 参与者按1:1随机分配至12周结构化DTT干预组或标准ERP活性对照组。
- 主要结局用Y-BOCS测量强迫症严重程度,评估时间点为基线(T1)和12周治疗结束时(T2)。
关键数值与推荐
- 纳入标准:ICD-10诊断强迫症且Y-BOCS评分≥16。
- 干预组接受12周结构化DTT方案,对照组接受标准ERP治疗。
- 次要结局包括痛苦耐受(Distress Tolerance Scale)、抑郁症状(Beck Depression Inventory)、应对策略(DBT-Ways of Coping Checklist)、正念(Kentucky Inventory of Mindfulness Skills)和接纳(Acceptance and Action Questionnaire-II)。
临床怎么用
- 若证实有效,DTT可为存在情绪和认知障碍而难以耐受传统CBT/ERP的强迫症患者提供替代治疗选择。
局限性
- 单中心、开放标签设计可能引入实施偏倚和评估偏倚。
- 样本量80例,统计效能和结果外推性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obsessive-compulsive disorder (OCD) is a chronic and debilitating mental health condition that significantly impairs the quality of life. Although cognitive-behavioral therapy (CBT), particularly exposure and response prevention (ERP), is considered the gold standard, many patients remain symptomatic or find these approaches challenging due to emotional and cognitive barriers. Distress tolerance techniques (DTT), a component of dialectical behavior therapy (DBT), have demonstrated efficacy in various conditions, including substance dependence, binge eating, and depression, by managing negative emotional states and enhancing coping mechanisms beyond their original focus on borderline personality disorder. However, the application of DTT in the treatment of patients with OCD has not been extensively explored. This study aims to evaluate the efficacy of DTT in reducing OCD severity and improving psychological outcomes. METHODS: This prospective, single-center, open-label randomized controlled trial will recruit 80 adults (18-40 years) diagnosed with OCD (ICD-10 criteria, Y-BOCS score ≥ 16) from the Department of Psychiatry, All India Institute of Medical Sciences, Bhopal. Participants will be randomized 1:1 using a random number table to either the intervention or active control group. Participants in the intervention group will engage in a 12-week structured DTT program specifically tailored for obsessive-compulsive disorder (OCD), whereas those in the active control group will undergo standard treatment of exposure and response prevention (ERP). The primary outcome will be OCD severity, measured using the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). Secondary outcomes included distress tolerance (measured using the Distress Tolerance Scale), depressive symptoms (measured using the Beck Depression Inventory), coping strategies (measured using the Dialectical Behavior Therapy-Ways of Coping Checklist), mindfulness (measured using the Kentucky Inventory of Mindfulness Skills), and acceptance (measured using the Acceptance and Action Questionnaire-II). Outcomes for the treatment groups will be evaluated before randomization (baseline, T1) and 12 weeks (end of treatment, T2). The protocol was approved by the Institute Ethical Committee (approval number) and was performed in strict adherence to the Declaration of Helsinki formulated by the World Medical Association. DISCUSSION: This trial will explore the efficacy of distress tolerance techniques in patients with OCD. This study will provide evidence for a therapeutic approach that addresses the limitations of traditional CBT and improves outcomes for patients with OCD. TRIAL REGISTRATION: Central Trial Register of India CTRI/2024/09/073672. Registered on 21 December 2024.
引用
- Kumar M, Singh V, Kumar R, et al. Efficacy of distress tolerance techniques of dialectical behavior therapy in persons with obsessive-compulsive disorder: a study protocol for a randomized controlled trial. Trials. 2026. PMID: 41998696. doi:10.1186/s13063-026-09672-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。